Table 1.
Characteristics among all participants and stratified on treatment
| All Participants (N = 393) | Isoniazid + Rifapentine, 2013 only (N = 87) | Rifampin only, 2013 only (N = 82) | Isoniazid only, 2009 and 2013 (N = 224)a | p-value | |
|---|---|---|---|---|---|
| n (%)b | n (%)b | n (%)b | n (%)b | ||
| Genderc | 0.93 | ||||
| Female | 175 (44.5) | 38 (43.7) | 38 (46.3) | 99 (44.2) | |
| Age (years)c | 43.6 (15.0) | 43.2 (15.4) | 43.4 (13.1) | 43.8 (15.5) | 0.94 |
| Insuranced | 0.19 | ||||
| Private | 59 (18.0) | 10 (15.2) | 13 (22.0) | 36 (17.8) | |
| Government sponsored | 76 (23.2) | 16 (24.2) | 17 (28.8) | 43 (21.3) | |
| Charity care | 163 (49.9) | 34 (51.5) | 29 (49.2) | 100 (49.5) | |
| Other | 29 (8.9) | 6 (9.1) | 0 (0.0) | 23 (11.4) | |
| Race/Ethnicityc | <0.001 | ||||
| Caucasian | 30 (7.9) | 8 (9.9) | 3 (3.7) | 19 (8.8) | |
| African or African American | 94 (24.9) | 18 (22.2) | 20 (24.4) | 56 (26.1) | |
| Asian | 161 (42.6) | 19 (23.5) | 40 (48.8) | 102 (47.4) | |
| Mexican or Other Hispanic | 49 (13.0) | 11 (13.6) | 10 (12.2) | 28 (13.0) | |
| Pacific Islander | 32 (8.5) | 21 (25.9) | 6 (7.3) | 5 (2.3) | |
| Other | 12 (3.2) | 4 (4.9) | 3 (3.7) | 5 (2.3) | |
| Foreign Bornc | 341 (90.7) | 65 (79.3) | 79 (98.8) | 197 (92.1) | <0.001 |
| English Speakingc | 203 (52.5) | 60 (70.6) | 38 (46.3) | 105 (47.7) | 0.001 |
| Homeless/marginally housee | 45 (12.3) | 24 (31.2) | 2 (2.5) | 19 (9.1) | <0.001 |
| Number of other medical problemsc | 0.01 | ||||
| 0 | 178 (45.3) | 38 (43.7) | 51 (62.2) | 89 (39.7) | |
| 1-2 | 119 (30.3) | 29 (33.3) | 19 (23.2) | 71 (31.7) | |
| 3+ | 96 (24.4) | 20 (23.0) | 12 (14.6) | 64 (28.6) | |
| Number of medicationsc | <0.001 | ||||
| 0-1 | 139 (35.4) | 0 (0.0) | 56 (68.3) | 83 (37.1) | |
| 2-3 | 138 (35.1) | 57 (65.5) | 12 (14.6) | 69 (30.8) | |
| 3+ | 116 (29.5) | 30 (34.5) | 14 (17.1) | 72 (32.1) | |
| Any tobacco use at start of therapyc | 49 (12.5) | 19 (21.8) | 11 (13.4) | 19 (8.5) | 0.01 |
| Any alcohol at start of therapyc | 52 (13.2) | 21 (24.1) | 10 (12.2) | 21 (9.4) | 0.002 |
| Clinicc | <0.001 | ||||
| Infectious Diseases | 17 (4.3) | 8 (9.2) | 0 (0.0) | 9 (4.0) | |
| Public Health | 263 (66.9) | 69 (79.3) | 67 (81.7) | 127 (56.7) | |
| International Clinic | 68 (17.3) | 0 (0.0) | 15 (18.3) | 53 (23.7) | |
| Homeless Clinic | 18 (4.6) | 5 (5.8) | 0 (0.0) | 9 (4.0) | |
| Employee Health | 27 (6.9) | 5 (5.8) | 0 (0.0) | 22 (9.8) | |
| Type of Monitoringc | <0.001 | ||||
| Weekly DOT/Phone calls | 87 (22.2) | 84 (96.6) | 1 (1.2) | 2 (0.9) | |
| Monthly visit | 139 (35.5) | 2 (2.3) | 66 (80.5) | 71 (31.8) | |
| Less often | 166 (42.4) | 1 (1.2) | 15 (18.3) | 150 (67.3) | |
a 205/224 were treated in 2009 and 19/224 were treated in 2013. In 2009, 7/9 patients were treated in the Infectious Diseases Clinic, 123/127 at the Public Health clinic, 48/53 in International Clinic, 10/13 in the Homeless Clinic, and 17/22 in Employee Health
b All estimates are percents except for age which is a mean (standard deviation)
c Less than 5% of data missing; d 16.8% of data are missing; e 7.1% of data are missing